Key Points
- Director Mitchell Austin Rudy purchased 31,055 shares at $2.82 on April 9 for $87,575.10, boosting his holdings to 44,198 shares (a 236.29% increase).
- Bonk reported a quarterly loss of ($8.27) EPS, with a negative return on equity of 208.29% and a net margin of -1,993.19% on $1.82 million in revenue, and has a market cap of about $21.6 million.
- Analyst sentiment is negative—Weiss Ratings reiterated a "Sell (d-)" and the stock has an average "Sell" rating—while institutional investors hold roughly 12.55% after several firms initiated small positions.
Bonk, Inc. (NASDAQ:BNKK - Get Free Report) Director Mitchell Austin Rudy purchased 31,055 shares of the firm's stock in a transaction on Thursday, April 9th. The shares were acquired at an average price of $2.82 per share, for a total transaction of $87,575.10. Following the purchase, the director directly owned 44,198 shares of the company's stock, valued at approximately $124,638.36. This represents a 236.29% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink.
Bonk Price Performance
BNKK opened at $2.75 on Friday. Bonk, Inc. has a fifty-two week low of $2.29 and a fifty-two week high of $46.90. The business's fifty day simple moving average is $3.10. The firm has a market capitalization of $21.59 million, a P/E ratio of -0.36 and a beta of 2.10.
Bonk (NASDAQ:BNKK - Get Free Report) last posted its quarterly earnings results on Tuesday, March 31st. The company reported ($8.27) earnings per share for the quarter. Bonk had a negative return on equity of 208.29% and a negative net margin of 1,993.19%.The business had revenue of $1.82 million for the quarter.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reiterated a "sell (d-)" rating on shares of Bonk in a research note on Friday, March 27th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has an average rating of "Sell".
Get Our Latest Report on Bonk
Institutional Inflows and Outflows
Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. State Street Corp acquired a new position in Bonk during the 4th quarter worth about $33,000. Steward Partners Investment Advisory LLC acquired a new position in Bonk during the 4th quarter worth about $37,000. Jane Street Group LLC acquired a new position in Bonk during the 4th quarter worth about $96,000. Finally, Geode Capital Management LLC acquired a new position in Bonk during the 4th quarter worth about $128,000. Institutional investors and hedge funds own 12.55% of the company's stock.
About Bonk
(
Get Free Report)
Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema. The company primarily sell its products through third-party physical retail stores and partners. The company was formerly known as Jupiter Wellness, Inc and changed its name to Safety Shot, Inc in September 2023.
Further Reading
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
